Ptc Therapeutics (PTCT) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to -$32.6 million.
- Ptc Therapeutics' Interest & Investment Income rose 2167.08% to -$32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$138.1 million, marking a year-over-year increase of 1886.28%. This contributed to the annual value of -$167.0 million for FY2024, which is 2927.16% down from last year.
- Per Ptc Therapeutics' latest filing, its Interest & Investment Income stood at -$32.6 million for Q3 2025, which was up 2167.08% from -$30.4 million recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Interest & Investment Income registered a high of -$19.2 million during Q1 2021, and its lowest value of -$44.3 million during Q4 2023.
- Moreover, its 5-year median value for Interest & Investment Income was -$28.2 million (2023), whereas its average is -$30.0 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 31939.02% in 2021, then soared by 3019.54% in 2025.
- Quarter analysis of 5 years shows Ptc Therapeutics' Interest & Investment Income stood at -$22.5 million in 2021, then decreased by 8.88% to -$24.5 million in 2022, then tumbled by 80.71% to -$44.3 million in 2023, then increased by 7.26% to -$41.1 million in 2024, then increased by 20.62% to -$32.6 million in 2025.
- Its last three reported values are -$32.6 million in Q3 2025, -$30.4 million for Q2 2025, and -$34.1 million during Q1 2025.